Albert-Ludwigs-Universität Freiburg

The villoglandular Adenocarcinoma of the Cervix as a Tumor Model. A Literature Analysis (2020) Dietl A, Aumann K, Beckmann M Conference contribution Physical Activity and Exercise in Mild Cognitive Impairment and Dementia: An Umbrella Review of Intervention and Observational Studies (2020) Demurtas J, Schöne D, Torbahn G, Marengoni A, Grande G, Zou L, Petrovic M, et al. Journal article, Review article Increased IL-8 concentrations in the cerebrospinal fluid of patients with unipolar depression (2020) Kuzior H, Fiebich BL, Yousif NM, Saliba SW, Ziegler C, Nickel K, Maier SJ, et al. Journal article Alterations of intracerebral connectivity in epilepsy patients with secondary bilateral synchrony (2020) Hammen T, Reisert M, Juschkat W, Egger K, Urbach H, Zentner J, Beck J, et al. Journal article Isolation and ex vivo Expansion of Human Limbal Epithelial Progenitor Cells (2020) Polisetti N, Schlunck G, Reinhard T, Kruse F, Schlötzer-Schrehardt U Journal article Interviews with experts in rare diseases for the development of clinical decision support system software - a qualitative study (2020) Schaaf J, Prokosch HU, Boeker M, Schaefer J, Vasseur J, Storf H, Sedlmayr M Journal article Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease (2020) Vergnano M, Mockenhaupt M, Benzian-Olsson N, Paulmann M, Grys K, Mahil SK, Chaloner C, et al. Journal article Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy (2020) Vogel MME, Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Kirste S, Becker J, Burger IA, et al. Journal article Young EFIS - joining forces to support Early Career Researchers in Immunology (2020) Costas-Ramon S, Gil-Pulido J, Hahn AM, Mcallister E Journal article Safety analysis of the run-in phase (1st and 2nd cohort) of the IMMUNIB trial (AIO-HEP-0218/ass) - An open-label, single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced stage HCC (2020) Vogel A, Mueller DW, De Toni E, Siegler GM, Lindig U, Mueller T, Schultheiss M, et al. Conference contribution